<p>Dasatinib is indicated for the treatment of adults with:</p>

<ul>
	<li>Newly diagnosed Philadelphia chromosome-positive (Ph+)&nbsp;chronic myeloid leukemia&nbsp;(CML) in&nbsp;chronic phase.</li>
	<li>Chronic, accelerated, or&nbsp;myeloid&nbsp;or&nbsp;lymphoid&nbsp;blast phase&nbsp;Ph+ CML with resistance or intolerance to prior therapy including imatinib.</li>
	<li>Philadelphia chromosome-positive&nbsp;acute lymphoblastic leukemia&nbsp;(Ph+ ALL) with resistance or intolerance to prior therapy.</li>
</ul>